APYX
Apyx Medical·NASDAQ
--
--(--)
--
--(--)
3.62 / 10
Netural
Fund flow evaluation: 7.23/10 reflecting robust fund flow characteristics. Constructive overall, block, and Extra-large trends face headwinds from adverse Small, Medium, and Large developments, indicating positive money flow direction. Analyst coverage indicates overwhelmingly bullish analyst consensus with strong conviction. Rating distribution: Strong Buy(100.0%) among 1 analysts, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-16
InstitutionRoth Capital
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for APYX?
- APYX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.62/10 (Netural).
